Tuesday, August 19, 2025 12:10:39 PM
Leo:
Yeah, it has been frustrating especially for me....$11.50, $11, $10.50, and $10 all looked like pretty good "spots"....all were wrong!
I really liked Citrati's monthly chart which he showed earlier, I was, I think the only guy who recommended his post...
The All Important....200 Day ($9.29) is being approached today, hope it holds up.....some people swear by it (me too)
I have seen sharp take downs like this over many companies prior to some surprise reversals...thinking after these happened that some sort of arrangement was made with the mm's & hedge funds supporting it before making an "out of the blue" buy out or deal....not suggesting that necessarily for $AVLX.
I keep thinking that Missling is still in good shape with those Sept. 18th options with a strike price of $5.04....a nice position to be in with the hope that he uses the cashless exercise and ONLY sells enough to pay the taxes and keeps many shares.
If I remember correctly both you and Tom123 were thinking a price as low as $9....now you seem to think even lower!
Back to my closet peering out for a sign of life....maybe Doc328's Batman Double Top will be met with the other ear turning to a "cauliflower ear" from a punch from Mohammed Ali....lol
Yeah, it has been frustrating especially for me....$11.50, $11, $10.50, and $10 all looked like pretty good "spots"....all were wrong!
I really liked Citrati's monthly chart which he showed earlier, I was, I think the only guy who recommended his post...
The All Important....200 Day ($9.29) is being approached today, hope it holds up.....some people swear by it (me too)
I have seen sharp take downs like this over many companies prior to some surprise reversals...thinking after these happened that some sort of arrangement was made with the mm's & hedge funds supporting it before making an "out of the blue" buy out or deal....not suggesting that necessarily for $AVLX.
I keep thinking that Missling is still in good shape with those Sept. 18th options with a strike price of $5.04....a nice position to be in with the hope that he uses the cashless exercise and ONLY sells enough to pay the taxes and keeps many shares.
If I remember correctly both you and Tom123 were thinking a price as low as $9....now you seem to think even lower!
Back to my closet peering out for a sign of life....maybe Doc328's Batman Double Top will be met with the other ear turning to a "cauliflower ear" from a punch from Mohammed Ali....lol
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
